Sustained expression of vascular endothelial growth factor and angiopoietin-1 improves blood-spinal cord barrier integrity and functional recovery after spinal cord injury

Journal of Neurotrauma

Volumn 27, Issue 11, 2010, Pages 2067-2076

  Herrera, Juan J ^a   Sundberg, Laura M ^a   Zentilin, Lorena ^b   Giacca, Mauro ^b,c   Narayana, Ponnada A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

angiopoietin 1; magnetic resonance imaging; traumatic spinal cord injury; vascular endothelial growth factor; viral mediated transfection

Indexed keywords

ANGIOPOIETIN 1; VASCULOTROPIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANGIOGENESIS; ARTICLE; BLOOD BRAIN BARRIER; CELL INFILTRATION; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFICACY; FAR WESTERN BLOTTING; FUNCTIONAL ASSESSMENT; LOCOMOTION; MALE; MEMBRANE DAMAGE; MICROGLIA; MOTOR ACTIVITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; SPINAL CORD; SPINAL CORD INJURY; STABLE EXPRESSION; TREATMENT OUTCOME; VIRUS EXPRESSION;

ANGIOPOIETIN-1; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; HINDLIMB; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MAGNETIC RESONANCE IMAGING; MALE; MICROINJECTIONS; MOTOR ACTIVITY; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78649346412     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2010.1403     Document Type: Article

References (62)

1. Arsic, N., Zentilin, L., Zacchigna, S., Santoro, D., Stanta, G., Salvi, A., Sinagra, G., and Giacca, M. (2003). Induction of functional neovascularization by combined VEGF and an-giopoietin-1 gene transfer using AAV vectors. Mol. Ther. 7, 450-459.
2. Basso, D.M., Beattie, M.S., and Bresnahan, J.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21.
3. Benest, A.V., Salmon, A.H., Wang, W., Glover, C.P., Uney, J., Harper, S.J., and Bates, D.O. (2006). VEGF and angiopoietin-1 stimulate different angiogenic phenotypes that combine to enhance functional neovascularization in adult tissue. Micro-circulation 13, 423-437.
4. Bilgen, M., Abbe, R., and Narayana, P.A. (2001). Dynamic contrast-enhanced MRI of experimental spinal cord injury: in vivo serial studies. Magn. Reson. Med. 45, 614-622.
5. Bitto, A., Minutoli, L., Galeano, M.R., Altavilla, D., Polito, F., Fiumara, T., Calo, M., Lo Cascio, P., Zentilin, L., Giacca, M., and Squadrito, F. (2008). Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression. Clin. Sci. (Lond.) 114, 707-718.
6. Bresnahan, J.C., Beattie, M.S., Todd, F.D., 3rd, and Noyes, D.H. (1987). A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device. Exp. Neurol. 95, 548-570.
7. Carlson, S.L., Parrish, M.E., Springer, J.E., Doty, K., and Dossett, L. (1998). Acute inflammatory response in spinal cord following impact injury. Exp. Neurol. 151, 77-88.
8. Chen, F., Tan, Z., Dong, C.Y., Chen, X., and Guo, S.F. (2007a). Adeno-associated virus vectors simultaneously encoding VEGF and angiopoietin-1 enhances neovascularization in is-chemic rabbit hind-limbs. Acta Pharmacol. Sin. 28, 493-502.
9. Chen, F., Tan, Z., Dong, C.Y., Li, X., Xie, Y., Wu, Y., Chen, X., and Guo, S. (2007b). Combination of VEGF(165)/Angiopoietin-1 gene and endothelial progenitor cells for therapeutic neo-vascularization. Eur. J. Pharmacol. 568, 222-230.
10. Cohen, D.M., Patel, C.B., Ahobila-Vajjula, P., Sundberg, L.M., Chacko, T., Liu, S.J., and Narayana, P.A. (2009). Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI. NMR Biomed. 22, 332-341.
11. Croll, S.D., and Wiegand, S.J. (2001). Vascular growth factors in cerebral ischemia. Mol. Neurobiol. 23, 121-135.
12. Croll, S.D., Ransohoff, R.M., Cai, N., Zhang, Q., Martin, F.J., Wei, T., Kasselman, L.J., Kintner, J., Murphy, A.J., Yancopoulos, G.D., and Wiegand, S.J. (2004). VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp. Neurol. 187, 388-402.
13. Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, D.L., Jain, V., Ryan, T.E., Bruno, J., Radziejewski, C., Maisonpierre, P.C., and Yancopoulos, G.D. (1996). Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161-1169.
14. Deo, A.A., Grill, R.J., Hasan, K.M., and Narayana, P.A. (2006). In vivo serial diffusion tensor imaging of experimental spinal cord injury. J. Neurosci. Res. 83, 801-810.
15. Fehlings, M.G., Tator, C.H., and Linden, R.D. (1989). The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroencephalogr. Clin. Neurophysiol. 74, 241-259.
16. Fenyes, D.A., and Narayana, P.A. (1998). In vivo echo-planar imaging of rat spinal cord. Magn. Reson. Imaging 16, 1249-1255.
17. Ferrara, N., Gerber, H.P., and LeCouter, J. (2003). The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
18. Findley, C.M., Cudmore, M.J., Ahmed, A., and Kontos, C.D. (2007). VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler. Thromb. Vasc. Biol. 27, 2619-2626.
19. Fisher, K.J., Jooss, K., Alston, J., Yang, Y., Haecker, S.E., High, K., Pathak, R., Raper, S.E., and Wilson, J.M. (1997). Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3, 306-312.
20. Greenberg, D.A., and Jin, K. (2005). From angiogenesis to neu-ropathology. Nature 438, 954-959.
21. Han, S., Arnold, S.A., Sithu, S.D., Mahoney, E.T., Geralds, J.T., Tran, P., Benton, R.L., Maddie, M.A., D'Souza, S.E., Whitte-more, S.R., and Hagg, T. (2010). Rescuing vasculature with intravenous angiopoietin-1 and alphavbeta3 integrin peptide is protective after spinal cord injury. Brain 133, 1026-1042.
22. Harrigan, M.R., Ennis, S.R., Sullivan, S.E., and Keep, R.F. (2003). Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Acta Neurochir. (Wien.) 145, 49-53.
23. Hausmann, O.N. (2003). Post-traumatic inflammation following spinal cord injury. Spinal Cord 41, 369-378.
24. Hayashi, T., Abe, K., and Itoyama, Y. (1998). Reduction of is-chemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J. Cereb. Blood Flow Metab. 18, 887-895.
25. Hermens, W.T., and Verhaagen, J. (1998). Viral vectors, tools for gene transfer in the nervous system. Prog. Neurobiol. 55, 399-432.
26. Herrera, J.J., Nesic-Taylor, D.O., and Narayana, P.A. (2009). Reduced vascular endothelial growth factor expression in contusive spinal cord injury. J. Neurotrauma 26, 995-1003.
27. Holtz, A., Nystrom, B., and Gerdin, B. (1990). Relation between spinal cord blood flow and functional recovery after blocking weight-induced spinal cord injury in rats. Neurosurgery 26, 952-957.
28. Hori, S., Ohtsuki, S., Hosoya, K., Nakashima, E., Terasaki, T. (2004). A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary en-dothelial cells through Tie-2 activation in vitro. J. Neurochem. 89, 503-513.
29. Kaya, D., Gursoy-Ozdemir, Y., Yemisci, M., Tuncer, N., Aktan, S., and Dalkara, T. (2005). VEGF protects brain against focal ischemia without increasing blood-brain permeability when administered intracerebroventricularly. J. Cereb. Blood Flow Metab. 25, 1111-1118.
30. Lang-Lazdunski, L., Matsushita, K., Hirt, L., Waeber, C., Von-sattel, J.P., Moskowitz, M.A., and Dietrich, W.D. (2000). Spinal cord ischemia. Development of a model in the mouse. Stroke 31, 208-213.
31. Lee, S.W., Kim, W.J., Jun, H.O., Choi, Y.K., and Kim, K.W. (2009). Angiopoietin-1 reduces vascular endothelial growth factor-induced brain endothelial permeability via upregula-tion of ZO-2. Int. J. Mol. Med. 23, 279-284.
32. Lin, T.N., Wang, C.K., Cheung, W.M., and Hsu, C.Y. (2000). Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 20, 387-395.
33. Liu, Y., Figley, S., Spratt, S.K., Lee, G., Ando, D., Surosky, R., and Fehlings, M.G. (2010). An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury. Neurobiol. Dis. 37, 384-393.
34. Means, E.D., and Anderson, D.K. (1983). Neuronophagia by leukocytes in experimental spinal cord injury. J. Neuropathol. Exp. Neurol. 42, 707-719.
35. Mills, C.D., Grady, J.J., and Hulsebosch, C.E. (2001). Changes in exploratory behavior as a measure of chronic central pain following spinal cord injury. J. Neurotrauma 18, 1091-1105.
36. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22.
37. Nourhaghighi, N., Teichert-Kuliszewska, K., Davis, J., Stewart, D.J., and Nag, S. (2003). Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis. Lab. Invest. 83, 1211-1222.
38. Patel, C.B., Cohen, D.M., Ahobila-Vajjula, P., Sundberg, L.M., Chacko, T., and Narayana, P.A. (2009). Effect of VEGF Treatment on the blood-spinal cord barrier permeability in experimental spinal cord injury: Dynamic contrast-enhanced magnetic resonance imaging. J. Neurotrauma 26, 1005-1016.
39. Peng, X.M., Zhou, Z.G., Glorioso, J.C., Fink, D.J., and Mata, M. (2006). Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury. Ann. Neurol. 59, 843-851.
40. Popovich, P.G., and Jones, T.B. (2003). Manipulating neuroin-flammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol. Sci. 24, 13-17.
41. Proescholdt, M.A., Jacobson, S., Tresser, N., Oldfield, E.H., and Merrill, M.J. (2002). Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J. Neuropathol. Exp. Neurol. 61, 914-925.
42. Rivlin, A.S., and Tator, C.H. (1977). Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J. Neurosurg. 47, 577-581.
43. Scheff, S.W., Rabchevsky, A.G., Fugaccia, I., Main, J.A., and Lumpp, J.E, Jr. (2003). Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma 20, 179-193.
44. Scheff, S.W., Saucier, D.A., and Cain, M.E. (2002). A statistical method for analyzing rating scale data: the BBB locomotor score. J. Neurotrauma 19, 1251-1260.
45. Schnell, L., Fearn, S., Klassen, H., Schwab, M.E., and Perry, V.H. (1999). Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur. J. Neurosci. 11, 3648-3658.
46. Snyder, R.O., Spratt, S.K., Lagarde, C., Bohl, D., Kaspar, B., Sloan, B., Cohen, L.K., and Danos, O. (1997). Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther. 8, 1891-1900.
47. Suidan, G.L., Dickerson, J.W., Chen, Y., McDole, J.R., Tripathi, P., Pirko, I., Seroogy, K.B., and Johnson, A.J. (2010). CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. J. Immunol. 184, 1031-1040.
48. Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X.O., Logvinova, A., and Greenberg, D.A. (2003). VEGF-induced neuroprotection, neu-rogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111, 1843-1851.
49. Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., Sato, T.N., and Yancopoulos, G.D. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
50. Svensson, E.C., Marshall, D.J., Woodard, K., Lin, H., Jiang, F., Chu, L., and Leiden, J.M. (1999). Efficient and stable trans-duction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation 99, 201-205.
51. Taoka, Y., and Okajima, K. (2000). Role of leukocytes in spinal cord injury in rats. J. Neurotrauma 17, 219-229.
52. Tator, C.H., and Fehlings, M.G. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26.
53. Tator, C.H. (1991). Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie 37, 291-302.
54. Thurston, G., Rudge, J.S., Ioffe, E., Zhou, H., Ross, L., Croll, S.D., Glazer, N., Holash, J., McDonald, D.M., and Yancopoulos, G.D. (2000). Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6, 460-463.
55. Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T.N., Yan-copoulos, G.D., and McDonald, D.M. (1999). Leakage-resistant blood vessels in mice transgenically overexpressing angio-poietin-1. Science 286, 2511-2514.
56. Tofts, P.S., Brix, G., Buckley, D.L., Evelhoch, J.L., Henderson, E., Knopp, M.V., Larsson, H.B., Lee, T.Y., Mayr, N.A., Parker, G.J., Port, R.E., Taylor, J., and Weisskoff, R.M. (1999). Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging. 10, 223-232.
57. Weirich, S.D., Cotler, H.B., Narayana, P.A., Hazle, J.D., Jackson, E.F., Coupe, K.J., McDonald, C.L., Langford, L.A., and Harris, J.H., Jr. (1990). Histopathologic correlation of magnetic resonance imaging signal patterns in a spinal cord injury model. Spine 15, 630-638.
58. Widenfalk, J., Lipson, A., Jubran, M., Hofstetter, C., Ebendal, T., Cao, Y., and Olson, L. (2003). Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience 120, 951-960.
59. Zacchigna, S., Tasciotti, E., Kusmic, C., Arsic, N., Sorace, O., Marini, C., Marzullo, P., Pardini, S., Petroni, D., Pattarini, L., Moimas, S., Giacca, M., and Sambuceti, G. (2007). In vivo imaging shows abnormal function of vascular endothelial growth factor-induced vasculature. Hum. Gene Ther. 18, 515-524.
60. Zhang, Z.G., Zhang, L., Croll, S.D., and Chopp, M. (2002a). Angiopoietin-1 reduces cerebral blood vessel leakage and is-chemic lesion volume after focal cerebral embolic ischemia in mice. Neuroscience 113, 683-687.
61. Zhang, Z.G., Zhang, L., Tsang, W., Soltanian-Zadeh, H., Morris, D., Zhang, R., Goussev, A., Powers, C., Yeich, T., and Chopp, M. (2002b). Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 22, 379-392.
62. Zhao, Y., Li, Z., Wang, R., Wei, J., Li, G., and Zhao, H. (2009). Angiopoietin 1 counteracts vascular endothelial growth factor-induced blood-brain barrier permeability and alleviates ischemic injury in the early stages of transient focal cerebral ischemia in rats. Neurol. Res. 32, 748-755.